|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
752 |
$71,394.88 |
3.59% |
| Align Technology, Inc. |
ALGN |
016255101 |
338 |
$62,425.22 |
3.14% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$55,156.79 |
2.77% |
| Penumbra, Inc. |
PEN |
70975L107 |
163 |
$54,143.71 |
2.72% |
| Masimo Corporation |
MASI |
574795100 |
294 |
$52,446.66 |
2.64% |
| Waters Corporation |
WAT |
941848103 |
159 |
$52,625.82 |
2.64% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,985 |
$50,030.50 |
2.51% |
| Alcon Inc. |
ALC.SW |
H01301128 |
589 |
$47,466.99 |
2.39% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
99 |
$46,254.78 |
2.32% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,046 |
$46,060.69 |
2.31% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,550 |
$45,090.93 |
2.27% |
| Revvity, Inc. |
RVTY |
714046109 |
482 |
$45,071.82 |
2.27% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
576 |
$45,043.20 |
2.26% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
599 |
$44,727.33 |
2.25% |
| Teleflex Incorporated |
TFX |
879369106 |
356 |
$44,574.76 |
2.24% |
| The Cooper Companies, Inc. |
COO |
216648501 |
622 |
$44,541.42 |
2.24% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$44,270.49 |
2.22% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
393 |
$43,842.03 |
2.20% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
163 |
$43,672.59 |
2.19% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
449 |
$43,337.48 |
2.18% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
81 |
$42,704.82 |
2.15% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
143 |
$41,788.89 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
210 |
$41,708.10 |
2.10% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
196 |
$41,717.76 |
2.10% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,415 |
$41,445.46 |
2.08% |
| DexCom, Inc. |
DXCM |
252131107 |
654 |
$41,169.30 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
180 |
$40,469.40 |
2.03% |
| Stryker Corporation |
SYK |
863667101 |
117 |
$40,467.96 |
2.03% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,205 |
$40,161.31 |
2.02% |
| Medtronic Plc |
MDT |
G5960L103 |
446 |
$39,301.52 |
1.98% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
539 |
$38,021.06 |
1.91% |
| Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$37,561.68 |
1.89% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
157 |
$37,293.37 |
1.87% |
| ResMed Inc. |
RMD |
761152107 |
156 |
$35,987.64 |
1.81% |
| Becton, Dickinson and Company |
BDX |
075887109 |
228 |
$35,506.44 |
1.78% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$35,488.61 |
1.78% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
778 |
$35,145.95 |
1.77% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,560 |
$34,924.04 |
1.76% |
| BioMerieux |
BIM.FP |
F1149Y232 |
320 |
$34,614.65 |
1.74% |
| Baxter International Inc. |
BAX |
071813109 |
1,939 |
$34,107.01 |
1.71% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
485 |
$32,770.27 |
1.65% |
| Abbott Laboratories |
ABT |
002824100 |
321 |
$32,437.05 |
1.63% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$30,258.45 |
1.52% |
| Cochlear Limited |
COH.AU |
Q25953102 |
229 |
$28,653.55 |
1.44% |
| Boston Scientific Corporation |
BSX |
101137107 |
446 |
$28,463.72 |
1.43% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
860 |
$27,469.30 |
1.38% |
| Insulet Corporation |
PODD |
45784P101 |
135 |
$27,201.15 |
1.37% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,487 |
$27,023.79 |
1.36% |
| US Dollar |
$USD |
|
3,749 |
$3,748.75 |
0.19% |
| Australian Dollar |
$AUD |
|
0 |
$0.00 |
0.00% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|